ClinicalTrials.Veeva

Menu

A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma.

S

Shanghai Jiao Tong University School of Medicine

Status

Unknown

Conditions

Pancreas Adenocarcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT04147403
ETMEFP_LYB_2019

Details and patient eligibility

About

The study of extended total mesopancreas excision(eTME) for pancreatic head adenocarcinoma is a retrospective multicenter cohort, collecting medical records and follow-up data of patients who underwent radical resection with pancreatic head adenocarcinoma.

Full description

The objectives of the study are as follows:

  1. To evaluate the perioperative safety of extended total mesopancreas excision(eTME) for patients who diagnosed with resectable pancreatic head adenocarcinoma.
  2. To demonstrate the prognosis of extended total mesopancreas excision(eTME) for patients who diagnosed with resectable pancreatic head adenocarcinoma.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with pancreatic head adenocarcinoma who underwent curative-intent resection.
  2. Patients with accessible medical records

Exclusion criteria

  1. Patients with unknown chemotherapy sequence or status
  2. Patients with history of previous malignant tumors
  3. Patients with distant metastases

Trial contacts and locations

4

Loading...

Central trial contact

Yingbin Liu, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems